Vincristine-induced neuropathy. A clinical study of fifty leukemic patients.
D000125:Achilles Tendon / Q000187:drug effects; D000200:Action Potentials / Q000187:drug effects; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003391:Cranial Nerves / Q000187:drug effects; D004357:Drug Synergism; D004568:Electrodiagnosis; D005684:Gait / Q000187:drug effects; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D009046:Motor Neurons / Q000187:drug effects; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000473:pathology; D009431:Neural Conduction / Q000187:drug effects; D010146:Pain / Q000139:chemically induced; D010243:Paralysis / Q000139:chemically induced; D011239:Prednisolone / Q000008:administration & dosage; D012021:Reflex, Abnormal / Q000139:chemically induced; D012677:Sensation / Q000187:drug effects; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects*
D014750:Vincristine; D011239:Prednisolone; D015122:Mercaptopurine; D008727:Methotrexate